[Clinical experiments of cephapirin in otorhino-laryngological field (author's transl)].
D000038:Abscess / Q000188:drug therapy; D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D004427:Ear Diseases / Q000151:congenital / Q000188:drug therapy; D005402:Fistula / Q000151:congenital / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D010033:Otitis Media / Q000188:drug therapy; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D010612:Pharyngitis / Q000188:drug therapy; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use; D013440:Sulfides / Q000627:therapeutic use; D014069:Tonsillitis / Q000188:drug therapy
D000081:Acetamides; D002511:Cephalosporins; D011725:Pyridines; D013440:Sulfides